Letters sent to healthcare professionals in July 2015

Last month, letters were sent regarding SGLT2 inhibitors and Xgeva▼ (denosumab).

Last month, letters were sent regarding:

Article citation: Drug Safety Update volume 9 issue 1 August 2015: 2

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.